Manager TitleAgeSince
Chief Executive Officer 56 2021-03-31
Director of Finance/CFO 46 2021-03-31
Director TitleAgeSince
Director/Board Member 65 2021-07-26
Director/Board Member - 2021-07-26
Date Insider Type Main position Quantity % Market Cap. Importance
7/28/23
Deerfield Management Co. LP
OthersCompany 1,600,000 7.7482%
8/5/21
Deerfield Management Co. LP
Issuer saleCompany 701,250 14.0250%
8/5/21
Deerfield Management Co. LP
Issuer saleCompany 731,250 14.6250%
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+0.29% - - 265M
-0.10%+4.07%+33.53%+109.85% 131B
+0.29%+4.06%+32.11%+86.04% 22.76B
-0.24%+4.04%+24.49%+61.10% 17.13B
+6.40%+0.69%+17.11%+164.39% 14.78B
+0.43%+3.82%+14.59%+30.43% 14.57B
+0.23%+4.14%-11.43%+14.21% 13.9B
-2.87%-7.22%-20.60%+50.83% 12.21B
+1.18%-0.89%+19.44%+34.48% 12.04B
-1.08%-5.99%+52.36%+71.90% 11.91B
Average +0.53%+0.40%+17.96%+69.25% 27.82B
Weighted average by Cap. +0.33%+1.48%+25.80%+89.33%
Logo DA32 Life Science Tech Acquisition Corp.
Da32 Life Science Tech Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for business combination targets in separate areas of the life sciences industry, including life sciences tools, diagnostics, synthetic biology, and data and analytics platforms. The Company is not engaged in any business operations and has not generated any revenue.
Employees
-
  1. Stock Market
  2. Stocks
  3. DALS Stock